Thierry Leveillard
16Patents
5h-index
22Co-inventors
62Inventor score
Filing activity: Apr 5, 2002 → Dec 12, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8518695B2 | Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2 | Chemistry; Metallurgy | 10 | Active |
| US8071745B2 | Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the same | Chemistry; Metallurgy | 10 | Active |
| US8114849B2 | Retinal dystrophy-associated protein and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US8394756B2 | Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells | Chemistry; Metallurgy | 9 | Active |
| US7795387B2 | Rod-derived cone viability factor (RDCVF) and a method of enhancing cone cell survival by RDCVF | Chemistry; Metallurgy | 8 | Expired |
| US8957043B2 | Methods of treating retinitis pigmentosa using nucleic acids encoding RDCVF1 or RDCVF2 | Chemistry; Metallurgy | 4 | Active |
| US8779093B2 | Neuronal viability factor and use thereof | Human Necessities | 3 | Active |
| US8193153B2 | Trophic factor for the treatment of retinal degenerative diseases | Human Necessities | 2 | Active |
| US10004780B2 | Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD) | Chemistry; Metallurgy | 2 | Active |
| US10668129B2 | Synergistic combination of neuronal viability factors and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9575075B2 | Methods for treating cone dystrophy with neuronal viability factor, RDCVF2 | Physics | 1 | Active |
| US11723988B2 | Methods of expressing a polynucleotide of interest in the cone photoreceptors of a subject comprising the subretinal delivery of a therapeutically effective amount of a recombinant AAV9-derived vector | Chemistry; Metallurgy | 0 | Active |
| US11428698B2 | Neuronal viability factor and use thereof in Alzheimer's disease | Physics | 0 | Active |
| US11313852B2 | Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders | Physics | 0 | Active |
| US11865189B2 | Transgenic RPE cells overexpressing OTX2 for the treatment of retinal degeneration | Chemistry; Metallurgy | 0 | Active |
| US10857239B2 | Methods for the treatment and diagnosis of Alzheimer's disease and traumatic brain injuries | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.